The global Edaravone Injection market size was estimated at USD 246 million in 2024 and is projected to reach USD 580.06 million by 2032, exhibiting a CAGR of 10.00% during the forecast period.
North America Edaravone Injection market size was estimated at USD 75.56 million in 2024, at a CAGR of 8.57% during the forecast period of 2025 through 2032.
Report Overview
Edaravone, sold as under the brand names Radicava and Radicut, is an intravenous medication used to help with recovery following a stroke[1] and to treat amyotrophic lateral sclerosis (ALS).
This report provides a deep insight into the global Edaravone Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Edaravone Injection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Edaravone Injection market in any manner.
Global Edaravone Injection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Market Segmentation (by Type)
Market Segmentation (by Application)
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
FAQs on Global Edaravone Injection Market (2024–2032)
1. What is the size of the Edaravone Injection market in 2024?
The global Edaravone Injection market is estimated to be worth USD 246 million in 2024.
2. What is the projected market value of Edaravone Injection by 2032?
By 2032, the market is expected to reach approximately USD 580.06 million.
3. What is the expected CAGR for the Edaravone Injection market?
The market is projected to grow at a Compound Annual Growth Rate (CAGR) of 10.00% from 2024 to 2032.
4. What is Edaravone Injection?
Edaravone is a medication used to treat amyotrophic lateral sclerosis (ALS), a neurodegenerative disease. It works by reducing oxidative stress and protecting nerve cells from damage. The injection form of Edaravone is primarily administered to patients to slow the progression of ALS.
5. Why is the Edaravone Injection market expected to grow?
The growth of the Edaravone Injection market is driven by:
-
Increasing incidence of ALS and other neurodegenerative diseases
-
Rising awareness and diagnosis of ALS
-
Advancements in medical research leading to improved treatment options
-
Growing demand for effective therapies for chronic, life-threatening diseases
-
Expanding approval and use of Edaravone in treating other conditions
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Edaravone Injection Market
- Overview of the regional outlook of the Edaravone Injection Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Customization of the Report
- In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
- Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
- Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Edaravone Injection Market and its likely evolution in the short to mid-term, and long term.
- Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
- Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
- Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
- Chapter 9 shares the main producing countries of Edaravone Injection, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
- Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
- Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
- Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
- Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Edaravone Injection
1.2 Key Market Segments
1.2.1 Edaravone Injection Segment by Type
1.2.2 Edaravone Injection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Edaravone Injection Market Overview
2.1 Global Market Overview
2.1.1 Global Edaravone Injection Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Edaravone Injection Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Edaravone Injection Market Competitive Landscape
3.1 Global Edaravone Injection Sales by Manufacturers (2019-2025)
3.2 Global Edaravone Injection Revenue Market Share by Manufacturers (2019-2025)
3.3 Edaravone Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Edaravone Injection Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Edaravone Injection Sales Sites, Area Served, Product Type
3.6 Edaravone Injection Market Competitive Situation and Trends
3.6.1 Edaravone Injection Market Concentration Rate
3.6.2 Global 5 and 10 Largest Edaravone Injection Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Edaravone Injection Industry Chain Analysis
4.1 Edaravone Injection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Edaravone Injection Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Edaravone Injection Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Edaravone Injection Sales Market Share by Type (2019-2025)
6.3 Global Edaravone Injection Market Size Market Share by Type (2019-2025)
6.4 Global Edaravone Injection Price by Type (2019-2025)
7 Edaravone Injection Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Edaravone Injection Market Sales by Application (2019-2025)
7.3 Global Edaravone Injection Market Size (M USD) by Application (2019-2025)
7.4 Global Edaravone Injection Sales Growth Rate by Application (2019-2025)
8 Edaravone Injection Market Consumption by Region
8.1 Global Edaravone Injection Sales by Region
8.1.1 Global Edaravone Injection Sales by Region
8.1.2 Global Edaravone Injection Sales Market Share by Region
8.2 North America
8.2.1 North America Edaravone Injection Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Edaravone Injection Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Edaravone Injection Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Edaravone Injection Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Edaravone Injection Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Edaravone Injection Market Production by Region
9.1 Global Production of Edaravone Injection by Region (2019-2025)
9.2 Global Edaravone Injection Revenue Market Share by Region (2019-2025)
9.3 Global Edaravone Injection Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Edaravone Injection Production
9.4.1 North America Edaravone Injection Production Growth Rate (2019-2025)
9.4.2 North America Edaravone Injection Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Edaravone Injection Production
9.5.1 Europe Edaravone Injection Production Growth Rate (2019-2025)
9.5.2 Europe Edaravone Injection Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Edaravone Injection Production (2019-2025)
9.6.1 Japan Edaravone Injection Production Growth Rate (2019-2025)
9.6.2 Japan Edaravone Injection Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Edaravone Injection Production (2019-2025)
9.7.1 China Edaravone Injection Production Growth Rate (2019-2025)
9.7.2 China Edaravone Injection Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Mitsubishi Tanabe Pharma
10.1.1 Mitsubishi Tanabe Pharma Edaravone Injection Basic Information
10.1.2 Mitsubishi Tanabe Pharma Edaravone Injection Product Overview
10.1.3 Mitsubishi Tanabe Pharma Edaravone Injection Product Market Performance
10.1.4 Mitsubishi Tanabe Pharma Business Overview
10.1.5 Mitsubishi Tanabe Pharma Edaravone Injection SWOT Analysis
10.1.6 Mitsubishi Tanabe Pharma Recent Developments
11 Edaravone Injection Market Forecast by Region
11.1 Global Edaravone Injection Market Size Forecast
11.2 Global Edaravone Injection Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Edaravone Injection Market Size Forecast by Country
11.2.3 Asia Pacific Edaravone Injection Market Size Forecast by Region
11.2.4 South America Edaravone Injection Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Edaravone Injection by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Edaravone Injection Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Edaravone Injection by Type (2025-2032)
12.1.2 Global Edaravone Injection Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Edaravone Injection by Type (2025-2032)
12.2 Global Edaravone Injection Market Forecast by Application (2025-2032)
12.2.1 Global Edaravone Injection Sales (K MT) Forecast by Application
12.2.2 Global Edaravone Injection Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Edaravone Injection Market Size Comparison by Region (M USD)
Table 5. Global Edaravone Injection Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Edaravone Injection Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Edaravone Injection Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Edaravone Injection Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Edaravone Injection as of 2022)
Table 10. Global Market Edaravone Injection Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Edaravone Injection Sales Sites and Area Served
Table 12. Manufacturers Edaravone Injection Product Type
Table 13. Global Edaravone Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Edaravone Injection
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Edaravone Injection Market Challenges
Table 22. Global Edaravone Injection Sales by Type (K MT)
Table 23. Global Edaravone Injection Market Size by Type (M USD)
Table 24. Global Edaravone Injection Sales (K MT) by Type (2019-2025)
Table 25. Global Edaravone Injection Sales Market Share by Type (2019-2025)
Table 26. Global Edaravone Injection Market Size (M USD) by Type (2019-2025)
Table 27. Global Edaravone Injection Market Size Share by Type (2019-2025)
Table 28. Global Edaravone Injection Price (USD/MT) by Type (2019-2025)
Table 29. Global Edaravone Injection Sales (K MT) by Application
Table 30. Global Edaravone Injection Market Size by Application
Table 31. Global Edaravone Injection Sales by Application (2019-2025) & (K MT)
Table 32. Global Edaravone Injection Sales Market Share by Application (2019-2025)
Table 33. Global Edaravone Injection Sales by Application (2019-2025) & (M USD)
Table 34. Global Edaravone Injection Market Share by Application (2019-2025)
Table 35. Global Edaravone Injection Sales Growth Rate by Application (2019-2025)
Table 36. Global Edaravone Injection Sales by Region (2019-2025) & (K MT)
Table 37. Global Edaravone Injection Sales Market Share by Region (2019-2025)
Table 38. North America Edaravone Injection Sales by Country (2019-2025) & (K MT)
Table 39. Europe Edaravone Injection Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Edaravone Injection Sales by Region (2019-2025) & (K MT)
Table 41. South America Edaravone Injection Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Edaravone Injection Sales by Region (2019-2025) & (K MT)
Table 43. Global Edaravone Injection Production (K MT) by Region (2019-2025)
Table 44. Global Edaravone Injection Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Edaravone Injection Revenue Market Share by Region (2019-2025)
Table 46. Global Edaravone Injection Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Edaravone Injection Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Edaravone Injection Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Edaravone Injection Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Edaravone Injection Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Mitsubishi Tanabe Pharma Edaravone Injection Basic Information
Table 52. Mitsubishi Tanabe Pharma Edaravone Injection Product Overview
Table 53. Mitsubishi Tanabe Pharma Edaravone Injection Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Mitsubishi Tanabe Pharma Business Overview
Table 55. Mitsubishi Tanabe Pharma Edaravone Injection SWOT Analysis
Table 56. Mitsubishi Tanabe Pharma Recent Developments
Table 57. Global Edaravone Injection Sales Forecast by Region (2025-2032) & (K MT)
Table 58. Global Edaravone Injection Market Size Forecast by Region (2025-2032) & (M USD)
Table 59. North America Edaravone Injection Sales Forecast by Country (2025-2032) & (K MT)
Table 60. North America Edaravone Injection Market Size Forecast by Country (2025-2032) & (M USD)
Table 61. Europe Edaravone Injection Sales Forecast by Country (2025-2032) & (K MT)
Table 62. Europe Edaravone Injection Market Size Forecast by Country (2025-2032) & (M USD)
Table 63. Asia Pacific Edaravone Injection Sales Forecast by Region (2025-2032) & (K MT)
Table 64. Asia Pacific Edaravone Injection Market Size Forecast by Region (2025-2032) & (M USD)
Table 65. South America Edaravone Injection Sales Forecast by Country (2025-2032) & (K MT)
Table 66. South America Edaravone Injection Market Size Forecast by Country (2025-2032) & (M USD)
Table 67. Middle East and Africa Edaravone Injection Consumption Forecast by Country (2025-2032) & (Units)
Table 68. Middle East and Africa Edaravone Injection Market Size Forecast by Country (2025-2032) & (M USD)
Table 69. Global Edaravone Injection Sales Forecast by Type (2025-2032) & (K MT)
Table 70. Global Edaravone Injection Market Size Forecast by Type (2025-2032) & (M USD)
Table 71. Global Edaravone Injection Price Forecast by Type (2025-2032) & (USD/MT)
Table 72. Global Edaravone Injection Sales (K MT) Forecast by Application (2025-2032)
Table 73. Global Edaravone Injection Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Edaravone Injection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Edaravone Injection Market Size (M USD), 2019-2032
Figure 5. Global Edaravone Injection Market Size (M USD) (2019-2032)
Figure 6. Global Edaravone Injection Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Edaravone Injection Market Size by Country (M USD)
Figure 11. Edaravone Injection Sales Share by Manufacturers in 2023
Figure 12. Global Edaravone Injection Revenue Share by Manufacturers in 2023
Figure 13. Edaravone Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Edaravone Injection Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Edaravone Injection Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Edaravone Injection Market Share by Type
Figure 18. Sales Market Share of Edaravone Injection by Type (2019-2025)
Figure 19. Sales Market Share of Edaravone Injection by Type in 2023
Figure 20. Market Size Share of Edaravone Injection by Type (2019-2025)
Figure 21. Market Size Market Share of Edaravone Injection by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Edaravone Injection Market Share by Application
Figure 24. Global Edaravone Injection Sales Market Share by Application (2019-2025)
Figure 25. Global Edaravone Injection Sales Market Share by Application in 2023
Figure 26. Global Edaravone Injection Market Share by Application (2019-2025)
Figure 27. Global Edaravone Injection Market Share by Application in 2023
Figure 28. Global Edaravone Injection Sales Growth Rate by Application (2019-2025)
Figure 29. Global Edaravone Injection Sales Market Share by Region (2019-2025)
Figure 30. North America Edaravone Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Edaravone Injection Sales Market Share by Country in 2023
Figure 32. U.S. Edaravone Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Edaravone Injection Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Edaravone Injection Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Edaravone Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Edaravone Injection Sales Market Share by Country in 2023
Figure 37. Germany Edaravone Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Edaravone Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Edaravone Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Edaravone Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Edaravone Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Edaravone Injection Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Edaravone Injection Sales Market Share by Region in 2023
Figure 44. China Edaravone Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Edaravone Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Edaravone Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Edaravone Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Edaravone Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Edaravone Injection Sales and Growth Rate (K MT)
Figure 50. South America Edaravone Injection Sales Market Share by Country in 2023
Figure 51. Brazil Edaravone Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Edaravone Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Edaravone Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Edaravone Injection Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Edaravone Injection Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Edaravone Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Edaravone Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Edaravone Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Edaravone Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Edaravone Injection Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Edaravone Injection Production Market Share by Region (2019-2025)
Figure 62. North America Edaravone Injection Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Edaravone Injection Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Edaravone Injection Production (K MT) Growth Rate (2019-2025)
Figure 65. China Edaravone Injection Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Edaravone Injection Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Edaravone Injection Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Edaravone Injection Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Edaravone Injection Market Share Forecast by Type (2025-2032)
Figure 70. Global Edaravone Injection Sales Forecast by Application (2025-2032)
Figure 71. Global Edaravone Injection Market Share Forecast by Application (2025-2032)
